The 2025 DIA China Annual Meeting will be held from May 22 – 25 (with ICH Day on May 22nd) in Shanghai Zhangjiang is an in-person conference, which has become the must-attend conference for all life science professionals working in lifecycle drug development, from discovery to marketed use in Asia.
2025 DIA China Meeting will continue to encourage open collaboration by bringing together representatives from the entire spectrum of the life science landscape and facilitating crucial multidisciplinary discussions across several tracks, such as will continue to be the trusty leader and strong supporter on Globalized Collaboration, Regulatory Innovation, Science & Technology Innovation, and Talent Innovation to forward looking collaboration and innovation can sustainability support in the future of healthcare.
2025 DIA China Annual Meeting will bring in more than 5000+ life cycle drug development professionals and over 300+ exhibitors from MNC & Local Pharma Companies, Clinical Study Sites and CROs/CDMOs from over 30 countries and regions. It encourages open collaboration by bringing together representatives from the entire spectrum of the life science landscape and facilitating crucial multidisciplinary discussions across several tracks, such as Regulatory Science, Patient Centered Clinical Drug Development, AI, Advanced Therapy Medicinal Products (ATMP), Pharmacovigilance and Drug Safety, Drug Development Strategy, Data Science and many more.
Boundaryless knowledge sharing, face to face interaction with global agencies and more Interactive activities only at 2025 DIA China Annual Meeting!
